课题基金 / 基金详情

GLUCOTROL EFFECTS ON HEPATIC GLUCOSE METABOLISM IN INSULIN RESISTANCE

GLUCOTROL EFFECTS ON HEPATIC GLUCOSE METABOLISM IN INSULIN RESISTANCE
葡萄糖三醇对胰岛素抵抗中肝葡萄糖代谢的影响
批准号：
6117137
负责人：
JOHN A TAYEK
金额：
$3.89万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6117137
关键词：
cachexia clinical research glipizide glucose metabolism human subject human therapy evaluation insulin sensitivity /resistance liver metabolism medical complication neoplasm /cancer noninsulin dependent diabetes mellitus nutrition related tag oral administration outcomes research

项目摘要

项目成果

JOHN A TAYEK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To study the effect of an oral hypoglycemic agent on glucose metabolism in Type II diabetics, normal subjects, and patients with cancer. Whether treatment with oral hypoglycemic agent can reverse the insulin resistance seen in cancer cachexia will be studied.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Arginine Treatment for Alcoholic Hepatitis
Arginine Treatment for Alcoholic Hepatitis
Arginine Treatment for Alcoholic Hepatitis
ABNORMAL GLUCONEOGENESIS IN TYPE II DIABETES
海外基金